CORE--CELL DISTRIBUTION/CHARACTERIZATION

$167,100P01FY2000CANIH

St. Jude Children'S Research Hospital, Memphis TN

Investigators

Linked publications & trials

Paper 38757485 Paper 38567652 Paper 37760578 Paper 36566574 Paper 35229329 Paper 33548339 Paper 32325418 Paper 31558580 Paper 31079218 Paper 30388705 Paper 30241221 Paper 30131386 Paper 29930752 Paper 29445162 Paper 28750090 Paper 28684529 Paper 28224700 Paper 28149961 Paper 28034080 Paper 27409525 Paper 27285804 Paper 27082077 Paper 26663785 Paper 26461056 Paper 26279473 Paper 26154614 Paper 26053707 Paper 25925418 Paper 25873648 Paper 25818285 Paper 25783402 Paper 25698082 Paper 25439599 Paper 25422914 Paper 25381958 Paper 24711551 Paper 24577551 Paper 24558066 Paper 24482196 Paper 24347168 Paper 24154873 Paper 23843622 Paper 23788485 Paper 23708972 Paper 23625626 Paper 23616418 Paper 23583129 Paper 23549869 Paper 23471653 Paper 23408929 Paper 23406775 Paper 23331792 Paper 23331791 Paper 23289916 Paper 23147804 Paper 23144714 Paper 23143218 Paper 23001593 Paper 22916091 Paper 22703801 Paper 22662276 Paper 22525412 Paper 22516936 Paper 22509977 Paper 22427570 Paper 22416839 Paper 22370329 Paper 22284765 Paper 22244414 Paper 22188815 Paper 22180392 Paper 22162460 Paper 22038993 Paper 22038920 Paper 21948167 Paper 21878236 Paper 21871868 Paper 21837651 Paper 21803003 Paper 21796439 Paper 21690471 Paper 21656756 Paper 21515735 Paper 21509928 Paper 21459080 Paper 21310526 Paper 21266077 Paper 21197468 Paper 21115884 Paper 21088257 Paper 20824063 Paper 20737561 Paper 20702149 Paper 20667604 Paper 20621735 Paper 20620303 Paper 20620299 Paper 20583968 Paper 20582939 Paper 20486170

Abstract

The purposes of the Cell Line Characterization Core facility are: 1) To provide investigators of the STPPG with well-characterized cell lines derived from solid tumors of pediatric patients; 2) to establish, on a limited basis, cell lines that are not currently available from tumors of pediatric patients; 3) to maintain a data base that will include, but will not be limited to, oncogene and tumor suppressor genes expressed by each cell line and DNA fingerprinting for consistent identification of each cell line; 4) To provide bulk culture for establishment of xenografts; and 5) To amplify and provide characterized adenovirus to in vitro and in vivo use in the outlined projects.

View original record on NIH RePORTER →